Collin Horner

Collin Horner is the Co-Founder and Chief Business Officer of Cura Therapeutics Inc., a biotech company focused on developing innovative immunotherapies for cancer and infectious diseases.12 With over 20 years of experience in business development, marketing, and communication, Horner brings valuable expertise to the company.13

Professional Background

Throughout his career, Horner has worked on various projects across different industries, including:

• Healthcare
• Real estate development
• Product branding

He has successfully launched numerous marketing and advertising campaigns for both global brands and early-stage startups.1

Role at Cura Therapeutics

At Cura Therapeutics, Horner's primary responsibilities include:

• Leading business development efforts
• Focusing on building strategic partnerships
• Securing funding to advance the company's technology towards clinical trials1

Currently, Horner is actively involved in raising the company's first seed round and series A funding.1

Company Overview

Cura Therapeutics, co-founded by Horner and Dr. Claudia A. Penafuerte Diaz, is developing a novel immunotherapy platform to treat solid malignancies. Their proprietary technology combines:

1. Reactivation of the immune system's response against cancer
2. Disruption of the tumor's blood supply

This unique approach sets Cura Therapeutics apart in the immuno-oncology market, as there are currently no treatments that combine these properties in a single therapeutic.2

Horner's expertise in business development and marketing, combined with Dr. Penafuerte Diaz's scientific background, forms a strong foundation for the company's growth and potential success in the biotech industry.